Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 303-311

  Kimura, Nobuyuki ^a   Tanemura, Kentaro ^b   Nakamura, Shin Ichiro ^c   Takashima, Akihiko ^b   Ono, Fumiko ^d   Sakakibara, Ippei ^d   Ishii, Yoshiyuki ^a   Kyuwa, Shigeru ^a   Yoshikawa, Yasuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Aging; Alzheimer's disease associated proteins; Cynomolgus monkeys; Nerve ending fraction; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; APOLIPOPROTEIN E; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; PRESENILIN 1; PROTEIN; PROTEIN P25; PROTEIN P35;

ADOLESCENT; AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LABORATORY; LABORATORY TEST; MONKEY; NERVE ENDING; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; WESTERN BLOTTING;

MACACA FASCICULARIS;

EID: 0141570702     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.012     Document Type: Article

References (47)

1. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
2. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:1992;672-674.
3. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
4. Murell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
5. Scheuer D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D.J., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
6. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
7. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Taylor Kimberly W., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature. 398:1999;513-517.
8. Xia W., Zhang J., Perez R., Koo E.H., Selkoe D.J. Interactions between amyloid precursor protein and presenilins in mammalian cells: implications for pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;8208-8213.
9. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kulu plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
10. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
11. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
12. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
13. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
14. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
15. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.S., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
16. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci. Lett. 174:1994;222-224.
17. Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.-X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
18. Poirier J., Davingnon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
19. Saunders A.M., Schmader K., Breitner J.C.S., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., Dole K.C., Schmechel D.E., Strittmatter W.J., Pericak-Vance M.A., Roses A.D. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
20. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H.St., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
21. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
22. Cross D., Vial C., Maccioni R.B. A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. J. Cell. Sci. 105:1993;51-60.
23. Kosik K.S., Joachim C.L., Selkoe D.L. Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 83:1986;4044-4048.
24. Maccioni R.B., Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol. Rev. 75:1995;835-864.
25. Mandelkow E.M., Biernat J., Drewes G., Gustke N., Trinczek B., Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging. 16:1995;355-363.
26. Imahori K., Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. 121:1997;179-188.
27. Ishiguro K., Omori A., Takamatsu M., Sato K., Arioka M., Uchida T., Imahori K. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148:1992;202-206.
28. Michel G., Mercken M., Murayama M., Noguchi K., Ishiguro K., Imahori H., Takashima A. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim. Biophys. Acta. 1380:1998;177-182.
29. 267 in the repeat domain. FEBS lett. 454:1999;157-164.
30. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147:1992;58-62.
31. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 402:1999;615-622.
32. Tsai L.H., Delalle I., Caviness V.S. Jr., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 371:1994;419-423.
33. Alvarez A., Munoz J.P., Maccioni R.B. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp. Cell. Res. 264:2001;266-274.
34. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., Yamaguchi H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31:1998;317-323.
35. Nakamura S., Nakayama H., Goto N., Ono F., Sakakibara I., Yoshikawa Y. Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J. Med. Primatol. 27:1998;244-252.
36. Kimura N., Nakamura S., Honda T., Takashima A., Nakayama H., Ono F., Sakakibara I., Doi K., Kawamura S., Yoshikawa Y. Age-related changes in the localization of presenilin-1 in cynomolgus monkey brain. Brain Res. 922:2001;30-41.
37. Tamai Y., Kojima H., Ohtani Y., Uchida K., Taguchi F., Kawaguchi T., Miura S., Tateishi J. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain. Microbiol. Immun. 33:1989;35-42.
38. Ma J., Yee A., Brewer H.B. Jr., Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:1994;92-94.
39. Sanan D.A., Weisgraber K.H., Russell S.J., Mahley R.W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A.D.et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest. 94:1994;860-869.
40. Podlisny M.B., Tolan D.R., Selkoe D.J. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Pathol. 138:1991;1423-1435.
41. Cai D., Leem J.Y., Greenfield J.P., Wang P., Wang R., Lopes K.O., Kim S.H., Zheng H., Greengard P., Sisodia S.S., Thinakaran G., Xu H. Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein. J. Biol. Chem. 278:2003;3446-3454.
42. Papp H., Pakaski M., Kasa P. Presenilin-1 and the amyloid precursor protein are transported bidirectionally in the sciatic nerve of adult rat. Neurochem. Int. 41:2002;429-435.
43. Terwel D., Dewachter L., Van Leuven F. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromol. Med. 2:2002;151-165.
44. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;7789-7793.
45. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
46. Tabira T., Chui D.H., Kuroda S. Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front. Biosci. 7:2002;44-49.
47. Tabira T., de Chui H., Nakayama H., Kuroda S., Shibuya M. Alzheimer's disease with spastic paresis and cotton wool type plaques. J. Neurosci. Res. 70:2002;367-372.